About this item:

104 Views | 67 Downloads

Author Notes:

Minming Zhang, Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009, China, Tel +86 571 87315255, Fax +86 571 87315255, Email cjr.zhangminming@vip.163.com

We are sincerely grateful to Dr Yesen Li for his excellent assistance in nanoparticle preparations. We also thank Dr Zhongcai Chen for his kind help with cell experiments and fluorescent staining. Technical support from Emory-Georgia Tech Nanotechnology Center for Personalized and Predictive Oncology and Zhejiang California Nanosystems Institute is acknowledged.

The authors have no conflicts of interest that are directly relevant to the content of this work.

Subjects:

Research Funding:

This research was supported by the Chinese National Programs for High Technology Research and Development (Grant No. 2006AA02Z485), Specific Prevention and Control Technology for Major Disease (Grant No. 2008C13027-2), Natural Science Foundation of Zhejiang Province (Grant No. J20060714), Special Foundation for Young Scientists of Zhejiang Province (Grant No. 2009QN009).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Nanoscience & Nanotechnology
  • Pharmacology & Pharmacy
  • Science & Technology - Other Topics
  • iron oxide nanoparticles
  • cytotoxicity
  • in vitro test
  • cytoskeleton
  • human umbilical vein endothelial cell
  • BIOMEDICAL APPLICATIONS
  • IN-VITRO
  • ACTIN CYTOSKELETON
  • PROGENITOR CELLS
  • MIGRATION
  • DEATH
  • ANGIOGENESIS
  • HYPERTHERMIA
  • PARTICLES
  • MRI

Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells

Journal Title:

INTERNATIONAL JOURNAL OF NANOMEDICINE

Volume:

Volume 5, Number 1

Publisher:

, Pages 385-399

Type of Work:

Article | Final Publisher PDF

Abstract:

Iron oxide nanoparticles (IONPs) have been employed for hyperthermia treatments, stem cell therapies, cell labeling, and imaging modalities. The biocompatibility and cytotoxic effects of iron oxide nanoparticles when used in biomedical applications, however, are an ongoing concern. Endothelial cells have a critical role in this research dealing with tumors, cardiovascular disease and inflammation. However, there is little information dealing with the biologic effects of IONPs on the endothelial cell. This paper deals with the influence of dextran and citric acid coated IONPs on the behavior and function of human umbilical vein endothelial cells (HUVECs). After exposing endothelial cells to IONPs, dose-dependent effects on HUVECs viability, cytoskeleton and function were determined. Both citric acid and dextran coated particles appeared to be largely internalized by HUVECs through endocytosis and contribute to eventual cell death possibly by apoptosis. Cytoskeletal structures were greatly disrupted, as evidenced by diminished vinculin spots, and disorganized actin fiber and tubulin networks. The capacity of HUVECs to form a vascular network on Matrigel™ diminished after exposure to IONPs. Cell migration/invasion were inhibited significantly even at very low iron concentrations (0.1 mM). The results of this study indicate the great importance of thoroughly understanding nanoparticle-cell interactions, and the potential to exploit this understanding in tumor therapy applications involving IONPs as thermo/chemoembolization agents.

Copyright information:

© 2010 Wu et al, publisher and licensee Dove Medical Press Ltd.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/).
Export to EndNote